The Role of Incentive Spirometry On Exercise Capacity, Breathing Symptoms, Depression Rate, and Quality of Life in NSCLC Patients with Chemotherapy

Apriliana, Dian dan Suradi, Suradi dan Rima, Ana (2021) The Role of Incentive Spirometry On Exercise Capacity, Breathing Symptoms, Depression Rate, and Quality of Life in NSCLC Patients with Chemotherapy. The role Incentive Spirometry On Exercise Capacity, Breathing Symptoms, Depression Rtae, and Quality of Life inNSCLC Patients with Chemotherapt, 2 (1). pp. 8-17. ISSN 2747-1306

Preview

Text 33-Article Text-236-2-10-20211103.pdf Download (227kB) | Preview

Abstract

Abstract
Backgrounds: Pulmonary rehabilitation is a non-pharmacological therapy that improves breathing capacity in lung cancer patients. This study aimed to determine the effects of incentive spirometry (IS) on exercise capacity, breathing symptoms, depression rates, and quality of life in lung cancer patients with chemotherapy.
Method: This quasi-experimental study was done through
purposive sampling of 32 lung cancer patients who underwent
chemotherapy for at least three cycles at Dr. Moewardi General Regional Hospital, Surakarta, from December 2019 to February 2020. Experimental group performed exercise using IS for four weeks alongside their standard chemotherapy, whereas control group received only standard chemotherapy. Data on 6 minutes walking test (6-MWT) to evaluate exercise capacity, breathing symptoms (BORG scale), level of depression (HRSD questionnaire), and quality of life (SGRQ questionnaire) in both groups were collected at baseline and at the end of the fourth week.
Results: Experimental group showed higher value of 6-MWT
(72.75±152.50 meters vs. 31.81 ± 27.67, P=0.010), a decrease in the BORG scale (-1.78±1.72 vs. -0.38±1.67, P=0.013), Hamilton's score improvement (-2.25±5.12 vs. -4.25±5.34, P=0.075), and improvement in the SGRQ value (-10.77±9.82 vs. -0.08±11.16, P=0.752) compared to those of control group.
Conclusion: Incentive spirometry significantly increased exercise capacity, reduced symptoms of shortness of breath lowered depression, and improved the quality of life for lung cancer patients with chemotherapy.
Keywords: 6-MWT, BORG, HRSD, SGRQ

Item Type:	Article
Subjects:	R Medicine > RZ Other systems of medicine
Divisions:	Fakultas Kedokteran > Kedokteran
Depositing User:	Dian Apriliana
Date Deposited:	08 Apr 2023 08:12
Last Modified:	08 Apr 2023 08:12
URI:	http://repository.uhamka.ac.id/id/eprint/23819

Actions (login required)

View Item